Eduardo Javier Sanchiz Yrazu
Director/Board Member at CAIXABANK, S.A.
Net worth: 42 216 $ as of 2024-03-30
Profile
Eduardo Javier Sanchiz Yrazu is currently the Director at Pierre Fabre SA since 2019.
He is also the Lead Independent Director at CaixaBank SA since 2017.
Additionally, he holds the position of Director at Sabadell Asabys Health Innovation Investments II FCR and Laboratorio Farmacéutico Pierre Fabre SA. In the past, Mr. Sanchiz Yrazu served as the Chief Executive Officer & Executive Director at Almirall SA from 2011 to 2017.
He also worked as the General Manager-Belgium & Mexico at Eli Lilly & Co. Furthermore, he was a Member at Farmaindustria and held various administrative roles at different pharmaceutical companies.
Mr. Sanchiz Yrazu pursued an MBA from Instituto de Empresa SL and completed his undergraduate studies at the University of Deusto.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CAIXABANK SA
0.00% | 2022-12-30 | 8,700 ( 0.00% ) | 42 216 $ | 2024-03-30 |
Eduardo Javier Sanchiz Yrazu active positions
| Companies | Position | Start |
|---|---|---|
| CAIXABANK, S.A. | Director/Board Member | 2017-09-20 |
| Laboratorio Farmacéutico Pierre Fabre SA | Director/Board Member | - |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Director/Board Member | 2019-06-13 |
Sabadell Asabys Health Innovation Investments II SCR SA
 Sabadell Asabys Health Innovation Investments II SCR SA Investment ManagersFinance Sabadell Asabys Health Innovation Investments II FCR invests in companies located in the Spain. The fund seeks investment opportunities in the fields of technology innovations and health sectors. It provides financing for early stage capital requirements. | Director/Board Member | - |
Former positions of Eduardo Javier Sanchiz Yrazu
| Companies | Position | End |
|---|---|---|
| Almirall Sp zoo | Corporate Officer/Principal | 2011-10-09 |
Almirall NV
 Almirall NV Pharmaceuticals: MajorHealth Technology Part of Grupo Corporativo Landon SL, Almirall NV is a Belgian company that manufactures and supplies pharmaceutical products. The private company is based in Sint-Lambrechts-Woluwe, Belgium. The CEOs are Peter Dangel, Steven Merckx, Xavier Chimonos. The company was founded in 1968. | Corporate Officer/Principal | 2011-08-31 |
| Almirall - Produtos Farmacêuticos Lda. | Corporate Officer/Principal | 2011-08-31 |
| Almirall International BV | Corporate Officer/Principal | 2011-08-31 |
Sofotec GmbH
 Sofotec GmbH Medical SpecialtiesHealth Technology Part of AstraZeneca PLC, Sofotec GmbH is a German company that manufactures and distributes pulmonary medical devices. The company is based in Bad Homburg vor der Höhe, Germany. The CEOs are Beatrix Fyrnys and Dafni Bika. The private company was founded in 2006. | Corporate Officer/Principal | 2011-06-30 |
Training of Eduardo Javier Sanchiz Yrazu
| Instituto de Empresa SL | Masters Business Admin |
| University of Deusto | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ALMIRALL, S.A. | Health Technology |
| CAIXABANK, S.A. | Finance |
| Private companies | 22 |
|---|---|
Pierre Fabre SA
Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
| Farmaindustria | |
| Laboratorios Berenguer Infale SA | |
| Laboratorios Almirall SL | |
Industrias Farmacéuticas Almirall SA
 Industrias Farmacéuticas Almirall SA Pharmaceuticals: MajorHealth Technology Part of Grupo Corporativo Landon SL, Industrias Farmacéuticas Almirall SA is a pharmaceutical company based in Barcelona, Spain. The Spanish company manufactures and sells pharmaceutical products. | Health Technology |
Ranke Química SA
 Ranke Química SA Pharmaceuticals: MajorHealth Technology Part of Grupo Corporativo Landon SL, Ranke Química SA is a pharmaceutical company based in Barcelona, Spain. The Spanish company manufactures pharmaceutical products. | Health Technology |
| Laboratorios Almofarma SL | |
Sofotec GmbH
Sofotec GmbH Medical SpecialtiesHealth Technology Part of AstraZeneca PLC, Sofotec GmbH is a German company that manufactures and distributes pulmonary medical devices. The company is based in Bad Homburg vor der Höhe, Germany. The CEOs are Beatrix Fyrnys and Dafni Bika. The private company was founded in 2006. | Health Technology |
| Almirall International BV | |
| Almirall Sp zoo | |
| Laboratorios Farmaceuticos Romofarm SL | |
| Laboratorios Miralfarma SL | |
Almirall NV
Almirall NV Pharmaceuticals: MajorHealth Technology Part of Grupo Corporativo Landon SL, Almirall NV is a Belgian company that manufactures and supplies pharmaceutical products. The private company is based in Sint-Lambrechts-Woluwe, Belgium. The CEOs are Peter Dangel, Steven Merckx, Xavier Chimonos. The company was founded in 1968. | Health Technology |
| Alprofarma SL | |
| Laboratorios Tecnobio SA | |
| Laboratorios Temis Farma SL | |
| Pantofarma SL | |
| American Chamber of Commerce of Mexico | |
Sabadell Asabys Health Innovation Investments II SCR SA
Sabadell Asabys Health Innovation Investments II SCR SA Investment ManagersFinance Sabadell Asabys Health Innovation Investments II FCR invests in companies located in the Spain. The fund seeks investment opportunities in the fields of technology innovations and health sectors. It provides financing for early stage capital requirements. | Finance |
| Laboratorio Farmacéutico Pierre Fabre SA | |
Almirall Hermal GmbH
 Almirall Hermal GmbH Pharmaceuticals: GenericHealth Technology Part of Grupo Corporativo Landon SL, Almirall Hermal GmbH produces and markets dermatological drugs. The private company is based in Reinbek, Germany. The CEOs are Alessandro Cappella, Alfredo Barón de Juan, David Nieto Ledesma. The German company was founded in 1943. | Health Technology |
| Almirall - Produtos Farmacêuticos Lda. |
- Stock Market
- Insiders
- Eduardo Javier Sanchiz Yrazu
